Search results
Mohan Rao Chintalagiri (born 19 January 1954, Huzurabad, Hyderabad State (now Telangana)) is an Indian molecular biologist renowned for his contributions to the fields of biophysics and molecular biology.
Jun 13, 2018 · Dr. Mohan Rao is the Chairman of Epsilon Economics LLC and Epsilon Life Sciences LLC. He is also the Chief Executive Officer of Expression Therapeutics, Inc., a biotechnology company focused on developing advanced therapies for hematology and oncology.
Dr. Mohan Rao is the Chief Executive Officer of Epsilon Economics and specializes in antitrust and intellectual property economics, with an emphasis on life sciences and technology. In 2018, he was recognized by the Intellectual Asset Magazine (IAM) as “among the foremost experts when it comes to pharmaceutical economics.”
Jan 4, 2024 · SEBI | Shri Govindayapalli Ram Mohan Rao takes charge as Executive Director, SEBI. Invitation of Applications for SEBI Grade 'A' Recruitment 2024 - General, Legal, Information Technology, Research, Engineering (Electrical) and Official Language Streams ::: For filing of Settlement Application in ISO Settlement Scheme, 2024, please click here.
Prof. Ch. Mohan Rao Research Interests: - Molecular Biology and Biophysics, Molecular chaperones in health and disease; the role of small heat shock proteins in gene expression, cell cycle, differentiation and apoptosis. Photodynamic Therapy, Retinoblastoma, cancer and eye diseases.
View Mohan Rao’s profile on LinkedIn, a professional community of 1 billion members.
- Millitronic Devices OPC Pvt. Ltd & Flowline Instrumentation Pvt. Ltd.
Dr. Ch. Mohan Rao is currently CSIR-Distinguished Scientist; he was the Director of the Centre for Cellular and Molecular Biology (CCMB), Hyderabad. He combines Biophysical, Molecular Biological and Cell Biological approaches to investigate problems of biomedical importance.
